Objective: To quantify the impact of organized cervical screening programs (OCSPs) on the incidence of invasive cervical cancer (ICC), comparing rates before and after activation of OCSPs. Methods: This population-based investigation, using individual data from cancer registries and OCSPs, included 3557 women diagnosed with ICC at age 25-74. years in 1995-2008. The year of full-activation of each OCSP was defined as the year when at least 40% of target women had been invited. Incidence rate ratios (IRRs) with 95% confidence intervals (95% CIs) were calculated as the ratios between age-standardized incidence rates observed in periods after full-activation of OCSPs vs those observed in the preceding quinquennium. Results: ICC incidence rates diminished with time since OCSPs full-activation: after 6-8. years, the IRR was 0.75 (95% CI: 0.67-0.85). The reduction was higher for stages IB-IV (IRR. =. 0.68, 95% CI: 0.58-0.80), squamous cell ICCs (IRR. =. 0.74, 95% CI: 0.64-0.84), and particularly evident among women aged 45-74. years. Conversely, incidence rates of micro-invasive (stage IA) ICCs increased, though not significantly, among women aged 25-44. years (IRR. =. 1.34, 95% CI: 0.91-1.96). Following full-activation of OCSPs, micro-invasive ICCs were mainly and increasingly diagnosed within OCSPs (up to 72%). Conclusion(s): Within few years from activation, organized screening positively impacted the already low ICC incidence in Italy and favored down-staging.

Changes in cervical cancer incidence following the introduction of organized screening in Italy

FERRETTI, Stefano;
2015

Abstract

Objective: To quantify the impact of organized cervical screening programs (OCSPs) on the incidence of invasive cervical cancer (ICC), comparing rates before and after activation of OCSPs. Methods: This population-based investigation, using individual data from cancer registries and OCSPs, included 3557 women diagnosed with ICC at age 25-74. years in 1995-2008. The year of full-activation of each OCSP was defined as the year when at least 40% of target women had been invited. Incidence rate ratios (IRRs) with 95% confidence intervals (95% CIs) were calculated as the ratios between age-standardized incidence rates observed in periods after full-activation of OCSPs vs those observed in the preceding quinquennium. Results: ICC incidence rates diminished with time since OCSPs full-activation: after 6-8. years, the IRR was 0.75 (95% CI: 0.67-0.85). The reduction was higher for stages IB-IV (IRR. =. 0.68, 95% CI: 0.58-0.80), squamous cell ICCs (IRR. =. 0.74, 95% CI: 0.64-0.84), and particularly evident among women aged 45-74. years. Conversely, incidence rates of micro-invasive (stage IA) ICCs increased, though not significantly, among women aged 25-44. years (IRR. =. 1.34, 95% CI: 0.91-1.96). Following full-activation of OCSPs, micro-invasive ICCs were mainly and increasingly diagnosed within OCSPs (up to 72%). Conclusion(s): Within few years from activation, organized screening positively impacted the already low ICC incidence in Italy and favored down-staging.
2015
Serraino, Diego; Gini, Andrea; Taborelli, Martina; Ronco, Guglielmo; Giorgi Rossi, Paolo; Zappa, Marco; Crocetti, Emanuele; Franzo, Antonella; Falcini, Fabio; Visioli, Carmen Beatriz; Stracci, Fabrizio; Zorzi, Manuel; Federico, Massimo; Michiara, Maria; Fusco, Mario; Ferretti, Stefano; Pannozzo, Fabio; Tisano, Francesco; Zanetti, Roberto; Zucchetto, Antonella; Zanier, L.; Clagnan, E.; Virdone, S.; Birri, S.; Naldoni, C.; Mancini, S.; Vattiato, R.; Monticelli, C.; Vitali, B.; Caldarella, A.; Manneschi, G.; Intrieri, T.; La Rosa, F.; Bianconi, F.; Spita, N.; Martinelli, N.; Vinti, G.; Baracco, S.; Baracco, M.; Bovo, E.; Turrin, A.; Dal Cin, A.; Iachetta, F.; Cirilli, C.; Bozzani, F.; Sgargi, P.; Lombardozzi, L.; Vitale, M. F.; Fusco, Maria; Panico, M.; Maione, C.; De Togni, A.; Marzola, L.; Migliari, E.; Carletti, N.; Carpanelli, M. C.; Bellardini, P.; Frateloreto, F.; Macci, L.; Busco, S.; Malignaggi, S.; Giubilato, P.; Patriarca, S.; Campari, C.; Caroli, S.; Di Felice, E.; Prandi, S.; Marani, E.; Casella, C.; Puppo, A.; Bonelli, L.; Piffer, S.; Gentilini, M. A.; Cappelletti, M.; Biavati, P.; Collina, N.; Petrucci, C.; Pandolfi, P.; Manfredi, M.; Seghini, P.; Borciani, E.; Castaing, M.; Sciacca, S.; Sciacchitano, S.; Benedetto, G.; Fidelbo, M.; Scuderi, T.; Pala, F.; Sini, G. M.; Canu, L.; Pintori, N.
File in questo prodotto:
File Dimensione Formato  
Ferretti.2015Preventive-Medicine.pdf

solo gestori archivio

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.09 MB
Formato Adobe PDF
1.09 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2338628
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 35
social impact